August 20, 2024
The US Food and Drug Administration (FDA) has approved lazertinib (Lazcluze) in combination with amivantamab-vmjw (Rybrevant) for upfront treatment of adults with locally advanced or metastatic […]
August 20, 2024
A new analysis has detected a signal of suicidal ideation associated with the glucagon-like peptide 1 receptor agonist (GLP-1 RA) semaglutide, especially among individuals concurrently using […]
August 20, 2024
Biotech startups worldwide are rushing to market screening tests that they claim can detect various cancers in early stages with just a few drops of blood. […]
August 20, 2024
The allegations against Algerian boxer Imane Khelif at the Paris Olympics raised the questions of intersexuality and its implications in competitive sports. Univadis Italy has decided […]
August 20, 2024
TOPLINE: Hydroxyurea does not significantly reduce ovarian reserve in girls and women with sickle cell disease. Fertility preservation measures before hydroxyurea treatment may not be necessary. […]
August 20, 2024
TOPLINE: Automated analysis of CT-derived body composition parameters, especially the visceral fat index, can predict the new-onset risk for type 2 diabetes (T2D) better than traditional […]
August 20, 2024
Having an ostomy is a dreaded prospect for many patients with rectal cancer. To defer, and potentially avoid, this life-altering surgery, the watch-and-wait approach has become […]
August 20, 2024
TOPLINE: Genetic variants associated with Parkinson’s disease (PD) are more common than previously thought and occur in 13% of individuals with the disease. The study highlights […]
August 20, 2024
While older patients with chronic kidney failure who opt to start dialysis show a modest survival benefit over those choosing only medical management, an important trade-off […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626
Next page